Evidence map›Paper›PMID 33415614›Full record

ArticleEnvironmental science and pollution research international2021

Ameliorative effects of 9-diaminoacridine derivative against Ehrlich ascites carcinoma-induced hepatorenal injury in mice.

Mabrouk Attia Abd Eldaim, Ehab Tousson, Ibrahim El Tantawy El Sayed, Asmaa Zakaria Abd Elmaksoud, Abdullah A S Ahmed

Abstract read
PubMed Publisher
In one paragraph

Article in Environmental science and pollution research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Chitosan andToxicology research · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Effect ofAntioxidants (Basel, Switzerland) · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Therapeutic Impact of Costus (Frontiers in pharmacology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mabrouk Attia Abd EldaimDepartment of Biochemistry and Chemistry of Nutrition, Faculty of Veterinary Medicine, Menoufia University, Sheben Elkom, Menoufia, 32511, Egypt. mabroukattia@vet.menofia.edu.eg.
Ehab ToussonZoology Department, Faculty of Science, Tanta University, Tanta, Egypt.
Ibrahim El Tantawy El SayedChemistry Department, Faculty of Science, Menoufia University, Sheben Elkom, 32511, Egypt.
Asmaa Zakaria Abd ElmaksoudChemistry Department, Faculty of Science, Menoufia University, Sheben Elkom, 32511, Egypt.
Abdullah A S AhmedChemistry Department, Faculty of Science, Menoufia University, Sheben Elkom, 32511, Egypt.
Menoufia University · EGTanta University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ehrlich ascites carcinoma induces hepatorenal injuries while acridine derivatives have antioxidant, anticancer, and anti-inflammatory. Thus, this study evaluated the protective potential of a newly synthesized the 9-diaminoacridine derivative (9-DAAD), N1-(acridin-9-yl) propane-1, 3-diamine hydrochloride, against Ehrlich ascites carcinoma (EAC) induced hepatorenal injury in female mice. Forty female mice were allocated into 4 groups. Group I was injected with 0.1% DMSO subcutaneously and kept a control. Group II received 9-DAAD (30 mg/kg bw/2 days) subcutaneously for 2 weeks. Group III was injected interaperitonealy with 2.5 × 10

Indexed as

Carcinoma, Ehrlich TumorAnimalsAscitesCell ProliferationFemaleLiverMiceVascular Endothelial Growth Factor AVascular Endothelial Growth Factor A9-Diaminoacridine (9-DADD)Alpha-fetoproteinCEAEhrlich ascites carcinomaVEGF

Identifiers

PMID33415614
OpenAlexW3120547932

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.